Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that early diagnosis and treatment are crucial for managing skin diseases in ferrets.

Hair loss due to scalp metastasis from breast cancer, known as Neoplastic Alopecia, has a better survival rate than other scalp metastases and requires a biopsy for diagnosis.

Asian women with breast cancer experience the highest rates of long-term hair loss and related distress after chemotherapy.

Most legal cases about 5α-reductase inhibitors, drugs for hair loss and prostate issues, complain about side effects and delayed cancer diagnosis, with most lawsuits settled out of court.

A cancer patient's hair became permanently curly after treatment with nivolumab.

Phospholipases help maintain and restore skin and hair health, potentially leading to new treatments for related conditions.

Social support improves empowerment and quality of life for breast cancer patients with hair loss.

The Hedgehog signaling pathway is important for skin and hair growth and can lead to cancer if it doesn't work right.

Removing MCPIP1 from myeloid cells in mice leads to hair loss and prevents skin tumors but causes pigmented spots.

The guidelines help doctors manage skin problems from certain cancer treatments to improve patients' lives.

Anthracycline and taxane chemotherapy cause significant side effects like fatigue, vomiting, nausea, nerve damage, joint pain, and hair loss in breast cancer patients.

Dutasteride effectively treats benign prostatic obstruction, improves urinary flow, reduces prostate size, and may prevent prostate cancer, but can cause sexual side effects.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Finasteride lowers PSA levels in men, certain factors increase testicular cancer risk, and current guidelines for penile cancer may lead to unnecessary surgeries.

Targeted cancer drugs can cause skin reactions, so dermatologists must manage these effects.

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

Implementing safety strategies is crucial to prevent radiation-related health issues.

The document does not confirm if radical prostatectomy is the best treatment for locally advanced prostate cancer.

Reporter characteristics affect detection of hair loss from cancer therapy.

Immune checkpoint inhibitors used in cancer therapy can cause hair loss, and understanding this can help manage the side effect.

Reporter characteristics affect detection of hair loss from cancer therapy.

Hair loss significantly influences medical decisions, affecting treatment choices and emotional well-being.

The structure of SRD5A reveals how it reduces steroids, aiding drug design for related health conditions.

The document concludes that scalp conditions have various causes and can present in many different ways.

The conclusion is that proper signaling is crucial for hair growth and development, and errors can lead to cancer or hair loss.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

Baldness, especially at the front, may lower the risk of testicular cancer by 31%, but its link to prostate cancer is unclear.

The paper concludes that breast cancer treatment involves complex interactions between medical symptoms, patient experiences, and commercial influences, requiring a holistic approach.

A new method helps manage skin side effects from hormonal cancer therapy, improving patient care.